| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.07 |